U.S. Renal Care (USRC), based in Plano, TX, has nearly doubled its business reach by acquiring Ambulatory Services of America (ASA), an evidence-based practice of dialysis and radiation oncology services in Brentwood, TN.
The merger will nearly double USRC’s current patient volume to about 14,000 with operations in more than 200 outpatient, home, and specialty hospital dialysis programs and facilities, business website Modern Healthcare reported. ASA had 79 dialysis centers at the time of the merger.
“Doubling the size of U.S. Renal Care means both greater access for patients and greater operational efficiency,” USRC CEO Chris Brengard said. “We could not have chosen a better partner than ASA, given our mutual commitment to personal, professional dialysis care and our emphasis on physician-led facilities.”
But even after doubling its dialysis business, the merged company stands at less than 10 percent of the total dialysis services market, according to ASA executive vice president and general counsel Doug Chappell, Modern Healthcare reported. The lion’s share comes from Fresenius Medical Care, based in Germany, and DaVita, based in Denver. According to the Fresenius website, Fresenius North America has 64 percent of the parent company’s approximately 257,916 patients, or about 165,000 patients.
As of June 30, 2013, DaVita reported operating or providing “administrative services at 2010 outpatient dialysis centers located in the United States serving approximately 159,000 patients.”
